Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Surface modification with functionally active heparin.

J Riesenfeld1, P Olsson, J Sanchez

  • 1Carmeda AB, Stockholm, Sweden.

Medical Device Technology
|February 7, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The artificial surface-induced whole blood inflammatory reaction revealed by increases in a series of chemokines and growth factors is largely complement dependent.

Journal of biomedical materials research. Part A·2007
Same author

On the blood compatibility of end-point immobilized heparin.

Journal of biomaterials science. Polymer edition·2001
Same author

Platelet compatibility of an artificial surface modified with functionally active heparin.

Thrombosis and haemostasis·1999
Same author

Single-day praziquantel versus 1-week albendazole for neurocysticercosis.

Neurology·1999
Same author

Increasing mixed haematopoietic chimaerism after BMT with total depletion of CD4+ and partial depletion of CD8+ lymphocytes is associated with a higher incidence of relapse.

Bone marrow transplantation·1999
Same author

C-->T mutation at -158 G gamma HPFH associated with 4 bp deletion (-225-222) in the promoter region of the A gamma gene in homozygous beta 0 39 nonsense thalassemia.

Haematologica·1999
Same journal

Safer arterial access.

Medical device technology·2010
Same journal

Building better surfaces.

Medical device technology·2010
Same journal

PVC: a broader perspective.

Medical device technology·2010
Same journal

Joining and forming using torsional ultrasonic principles.

Medical device technology·2010
Same journal

US regulation of combination products.

Medical device technology·2010
Same journal

Assessing biological safety of metals associated with medical devices.

Medical device technology·2010
See all related articles

End-point immobilization of heparin on artificial materials preserves its structure, maintaining anticoagulation activity. This surface modification effectively inhibits blood coagulation factors and reduces complement activation for improved hemocompatibility.

Area of Science:

  • Biomaterials Science
  • Surface Chemistry
  • Hematology

Background:

  • Artificial materials often require surface modifications to enhance blood compatibility.
  • Heparin coating is a common strategy to improve hemocompatibility, but its effectiveness can be compromised.
  • Heparin's anticoagulant activity relies on specific structural integrity for binding to antithrombin.

Purpose of the Study:

  • To investigate the efficacy of end-point immobilization of heparin for surface modification.
  • To determine if this method preserves heparin's functional structure and anticoagulant activity.
  • To assess the impact on coagulation factors and complement activation.

Main Methods:

  • Surface modification of artificial materials using end-point-immobilized heparin.

Related Experiment Videos

  • Assessment of heparin's structural integrity post-immobilization.
  • Evaluation of inhibition of coagulation factors.
  • Measurement of complement activation levels.

    • Main Results:

    • End-point immobilization successfully preserved the specific heparin structure essential for antithrombin binding.
    • The modified surfaces demonstrated significant inhibition of key coagulation factors.
    • Complement activation was notably minimized compared to conventional heparin coatings.

    Conclusions:

    • End-point immobilization is a superior method for coating artificial materials with heparin.
    • This technique maintains heparin's anticoagulant properties and reduces adverse immune responses.
    • Improved hemocompatibility is achieved by preserving heparin's functional structure.